Michael F. Byrne MD

Dr. Michael Byrne is CEO and founder of Satisfai Health Inc, a leading medical solutions provider specializing in AI applications applied to large addressable markets in gastroenterology. Its solutions deliver real-time analysis of medical imagery and provide clinicians with real-time decision-making intelligence that dramatically improve patient outcomes.

He is also the founder of the ai4gi joint venture for which he provides senior leadership and clinical direction. ai4gi is supporting the fight against colon cancer by applying Artificial Intelligence, with its recent deep learning techniques, to revolutionize medical image analysis. Outside the ai4gi Joint Venture, Dr. Byrne is guiding Satisfai Health in its vision of employing Artificial Intelligence to improve patient outcomes for a variety of GI tract diseases.

Dr. Byrne is a clinical innovator and physician entrepreneur with more than twenty years experience as a practicing physician and specialist in gastroenterology and interventional endoscopy who is widely regarded as a pioneer and leading global clinical expert on Artificial Intelligence as applied to Gastroenterology.

He has worked in the medical device space for several years. Prior to his role with Satisfai, and his work on the ai4gi project, he has worked with the Biotechnology Industry in several areas including colon cancer genetic testing, and novel applications of Photodynamic therapy for Gastrointestinal disease and has over 100 papers published in peer-reviewed journals.

Dr. Byrne is currently a Clinical Professor of Medicine in the Division of Gastroenterology and was the Director of Endoscopy at Vancouver General Hospital/University of British Columbia from 2012-2014. His research interests range from basic science to clinical medicine, and he has hands-on research training in molecular science and pharmacology.